Patients receiving anti-cancer treatment near end of life experience higher rates of hospitalization, ED and ICU use, and less utilization of hospice
Patients who receive systemic anti-cancer treatment near end of life are more likely to be hospitalized, go to the intensive care unit or emergency department, and are less likely to utilize hospice care in the final 30 days of life, according to researchers at Â鶹ӳ» MD Anderson Cancer Center. This pattern of care was observed in patients who received all types of systemic anticancer therapy, including cytotoxic...
